NCT04714372 2024-10-24
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
Masonic Cancer Center, University of Minnesota
Dartmouth-Hitchcock Medical Center
Instituto de Investigación Hospital Universitario La Paz
Massachusetts General Hospital